Chamber and committees

It is for individual Health Boards to ensure that communities have access to pharmacy services within a reasonable distance. However, in our strategy for pharmaceutical care in Scotland ‘Achieving Excellence in Pharmaceutical Care’ (2017) we committed to enhancing access to pharmaceutical care in remote and rural communities, which included use of Attend Anywhere for pharmacist clinics, and use of Near Me for remote and rural access to pharmaceutical care. We commissioned NES to work with remote and rural NHS Boards to explore mechanisms to attract more pharmacists and pharmacy technicians to work in remote and rural communities; ensuring any associated education and training needs are flexibly met. We also committed to testing a pharmacy longitudinal clerkship.

There are remote and rural longitudinal clerkships occurring in NHS Borders, NHS Dumfries and Galloway, NHS Highland, NHS Grampian and NHS Lanarkshire, all of which feed into a new piece of Additional Cost of Teaching Pharmacy research in collaboration with both Scottish Schools of Pharmacy.

In addition, to promote pharmacy technician recruitment in remote and rural areas, a number of senior pharmacy technicians attend school careers fairs etc to raise awareness of the role. All vacancies for the Pharmacy Technician Technical Apprenticeship are advertised on the Apprenticeships.scot website. Skills Development Scotland also provides an additional rural uplift for apprentices whose main employment and normal working hours are based in Argyll and Bute, Isle of Arran, Orkney, Shetland, and the Western Isles. Some of the Pre-registration Trainee Pharmacy Technicians in the remote and rural areas are undertaking placements in primary care and community pharmacy whilst undertaking the Technical Apprenticeship.

The Scottish Government continues to work with NHS National Education for Scotland (NES) and the Royal Pharmaceutical Society in developing a joint programme to encourage more students, and not just school leavers, to consider careers in pharmacy, including ensuring the output reaches deprived and remote and rural communities.

The Scottish Government welcomes the Our Union Street white paper and the range of ideas it captures.

The Scottish Government recognises that our cities and towns are a national asset and is pleased to see that many of the aims in the Our Union Street white paper align with aims of National Planning Framework 4.

The Scottish Government would encourage Our Union Street, as it progresses, to consider entering its achievements into the government’s new Scottish Planning Innovation Awards in the future.

The pharmaceutical industry continues to successfully support pandemic preparedness and resilience in Scotland, as described in the answer to question S6W-19343 on 11 July 2023.

All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government engages with the pharmaceutical industry directly as well as via the Association of the British Pharmaceutical Industry, and through Four Nations partners as part of UK-wide pandemic preparedness and resilience measures. This has ranged from long-standing arrangements to build and maintain stockpiles of medicines to address challenges from potential influenza pandemics to more recent measures to establish stockpiles of medicines and associated consumables for the response to COVID-19. Collaborative working across the UK also includes working in partnership with the pharmaceutical industry to develop onshore vaccine manufacturing capacity, with potential for pandemic deployment.

Ministers are offered a SG mobile telephone on appointment. Our records show costs per year as follows:

2018-19 - £2,210

2019-20 - £3,802

2020-21 - £1,490

2021-22 - £1,463

2022-23 - £10,957

Decisions about the appropriateness of referral to pain specialist services, or medications for pain management, are made by the clinician in discussion with the patient, and with reference to their medical history. Patients may choose to take the offer of new pathway alternatives being offered by some NHS Boards rather than by being seen at a consultant led clinic. Where a patient chooses an alternative pathway, they are removed from the waiting list for the consultant led clinic.

The Scottish Government is committed to rapidly improving care and services for people with chronic pain by delivering the Actions in the Pain Management Service Delivery Framework Implementation Plan at pace. The Implementation Plan outlines actions to expand skills and knowledge on chronic pain across local services and scaling-up new ways of working to improve the consistency and resilience of local pain services. We are investing in national solutions such as improving how people access information and understand their care options, enhancing coordination of support between the NHS and the third-sector.

We are also continuing to invest in the Scottish National Residential Pain Management Programme which provides highly specialised care for those facing the most challenging impacts of chronic pain to the value of over £630,000 this year.

I refer the member to the answer to question S6W-19380 on 11 July 2023. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at: https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The final report is currently going through the publication process and the Scottish Government is confident that this, and any associated recommendations, will be published in August 2023.

The information requested is not currently held centrally by the Scottish Government.

Gender reassignment surgery is a specialised field, and due to the highly specialist nature of this surgery, it is carried out in the UK under a four-nations contract, which is managed by NHS England’s Gender Dysphoria National Referral Support Service (GDNRSS). These surgeries are coordinated by NHS National Services Scotland (NSS) on behalf of NHS Scotland.

NSS is in discussion with NHS England’s GDNRSS around the regular provision of these data.

The Scottish Government is committed to ensuring all people living in Scotland with neurological conditions, such as Essential Tremor, are able to access the best possible care, support and benefit from healthcare services that are safe, effective and put people at the centre of their care.

Magnetic resonance-guided focused ultrasound (MRgFUS) was taken through the initial stages of the National Service Division’s National Specialist Services Committee assessment in 2018, which concluded there was insufficient evidence to support a formal national service at that time.

MRgFUS treatment is therefore currently provided on a trial basis in Scotland to help inform the evidence-base for the treatment and ensure that it is subject to rigorous clinical assessment to establish patient safety and efficacy before any decision on adopting it in the NHS. NHS Tayside have informed National Services Division that an application for national designation of the MRgFUS service in Dundee is expected to be submitted for 2024/25.

All decisions on a further referral to NHS England for any patient are the responsibility of the NHS Board where the patient resides. Specialist treatment outwith NHS Scotland is managed by the National Services Division as part of NHS National Services Scotland (NSS).

In the meantime, NSS is engaging with both clinicians in Dundee and colleagues in NHS England to determine how treatment might be made available more widely for eligible Scottish patients.